CardiaTec

Curated by Signal

AI-based drug discovery platform for researchers

Overview

AI-based drug discovery platform for researchers. The company is developing a target discovery platform leveraging AI to make sense of large-scale multi-omic cardiovascular data.

Key facts

Founded: 2021
Headquarters: Cambridge, United Kingdom
Stage: Sign up to view
Industry: Health Technology

Contact

Primary office: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Wired Differently
Provider of online counseling & coaching for mental health
Health TechnologyCheltenham, United Kingdom
MyPharmacyspace
Online retailer of pharmaceutical and medical consumables
Health TechnologyAylesbury, United Kingdom
MeloKura
App-based platform delivering frequency sound streams for optimizing health and wellbeing
Health TechnologyLondon, United Kingdom

About CardiaTec

What does CardiaTec do?

AI-based drug discovery platform for researchers.

Where is CardiaTec headquartered?

CardiaTec is headquartered in Cambridge, United Kingdom.

When was CardiaTec founded?

CardiaTec was founded in 2021.

Which sector is CardiaTec in?

CardiaTec operates in Health Technology.

Who are CardiaTec's competitors?

Companies similar to CardiaTec include Wired Differently, MyPharmacyspace, and MeloKura.